STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

STERIS plc

Capriza provides information on tracking apps, lifestyle tips, and relationship advice, self-described.

Capriza

WFHSS is an international organization focused on the promotion of the worldwide harmonization of sterilization departments and decontamination practices within healthcare facilities, self-described as a network of professional experts.

WFHSS

Ansana provides innovative surgical instrument reprocessing technology for healthcare markets in the US and Europe, self-described as setting a new standard for quality, sustainability, efficiency, and service.

Ansana

STERIS is a global provider of products and services that support patient care with an emphasis on infection prevention.

Metric
Company Name	STERIS plc	Capriza	WFHSS	Ansana
Symbol	STE
MSH ID	COM:STERIS	COM:CAPRIZA	COM:WFHSS	HEALTH:ANSANA
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Consumer Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Devices	Information Services	Medical Services	Medical Devices
Country	IE	US	CH	US
Stage				Seed Round
Employee Count	18K
Website	steris.com	capriza.com	wfhss.com	ansana.health
LinkedIn
Founders

Metric
Market Cap	21.29B
Enterprise Value
Monthly Web Traffic		1.39K
Web Traffic Growth
Valuation
Raised Capital		933.17K

Metric
Revenue	5.14B
Revenue (LTM)
Revenue (NTM)
Gross Profit	2.23B
EBITDA	1.47B
Operating Income	905.42M
Net Income	378.24M
EPS	3.83
Diluted EPS	3.81
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.45
Operating Profit Margin	0.16
EBITDA Margin	0.29
Net Profit Margin	0.10
Return on Equity	0.09
Return on Assets	0.05
Return on Capital Employed	0.10

COM:STERIS

STERIS

Last Close

215.77

22/11 21:00

Market Cap

21.29B

Beta: -

Volume Today

502.99K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	39.67
P/B Ratio	3.52
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	4.48
EV Multiple	20.35

Metric
Days Sales Outstanding	65.65
Days Payables Outstanding	36.32
Days Inventory Outstanding	102.40
Operating Cycle	167.47
Cash Conversion Cycle	134.35
Asset Turnover	0.54

Metric
Operating Cash Flow	973.27M
Free Cash Flow	612.95M
Cash Flow to Debt	0.45
Operating Cash Flow/Sales	0.18
Free Cash Flow Yield	0.02

Metric
Cash & Equivalents	207.02M
Accounts Receivable	-128.07M
Inventory	674.53M
Goodwill	4.07B
Debt to Capitalization	0.35
Debt to Assets	0.30
Current Ratio	2.49
Quick Ratio	2.36

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.02
SG&A to Revenue